Join The Satellite
Each month, you’ll receive the most important private market insights and Moonfare updates – straight to your inbox.
Private market activity has swung gently back into action in 2024. Will this momentum continue into 2025?
After a challenging 2023, when private equity deals, fundraising and exits were all markedly down on the previous two years, 2024 showed some signs of the start of a recovery.
Private equity deals to the end of Q3 2024 were up 36% by value and 18% by volume compared with the same period in 2023.¹ Fundraising reached par with last year in the US, with $236 billion raised in the first three quarters of 2024, according to Pitchbook.² In Europe, fundraising totalled €110 billion during the same period, not far off the €122 billion recorded for the whole of 2023, which was itself a strong year.³
The missing piece of the recovery puzzle remains exits, which have remained broadly flat this year — by Q3 2024, the value realised from private equity portfolios globally stood at $635 billion, versus $745 billion for full-year 2023.⁴ This stagnation is causing liquidity issues among many LPs and is dampening fundraising in some markets.
So what’s in store for the coming year? Here are some of Moonfare’s perspectives of what we can expect to play out during 2025.
Muted portfolio company sales over the past two years are leading to longer hold periods and ageing portfolios. The average holding period spiked to 5.8 years in 2023, before decreasing this year.⁵ Since buyout fund portfolios contain $3.2 trillion of capital in unsold companies,⁶ LPs are increasingly focusing GPs’ minds on releasing more cash so they can meet capital calls on existing funds and commit to new vehicles to maintain vintage year diversification.
Over 80% of GPs said they were under at least moderate pressure from their LPs to increase their distributions, according to an EY survey.⁷
Yet there are signs that exit activity could increase in 2025. With inflationary pressures now easing and interest rates falling, public market confidence has already improved. The MSCI World index was up 18% in the year to mid-November⁸ and the S&P was 25% higher than at the start of the year.⁹ Private equity firms spotted an opportunity to list companies in 2024, including EQT-backed dermatology business Galderma,¹⁰ Partners Group-backed KinderCare¹¹ and Carlyle-backed aircraft maintenance services business StandardAero.¹²
The coming year looks likely to be busier. Blackstone president Jonathan Gray has said his firm is preparing some of its portfolio companies for IPO¹³ such as medical equipment supplier Medline, which the firm co-owns with Carlyle and Hellman & Friedman, is reported to be among them.¹⁴ Meanwhile advisers, such as KPMG, report a building pipeline of IPOs slated for 2025.¹⁵
Yet IPOs are only part of the story. Until recently, the more active exit routes of sales to corporates and sponsors were hampered by a stubbornly wide bid-ask spread between buyers and sellers. A recent Goldman Sachs survey illustrates this clearly: 60% of GP respondents said that valuations were a challenge to deploying capital — the top response — while 53% said they were a challenge to exiting investments.¹⁶
However, a more stable (and likely declining) outlook for interest rates is making it easier for dealmakers to price risk. The price expectations gap between buyers and sellers is correspondingly narrowing, opening up more exit opportunities.
Each month, you’ll receive the most important private market insights and Moonfare updates – straight to your inbox.
Each month, you’ll receive the most important private market insights and Moonfare updates – straight to your inbox.
Each month, you’ll receive the most important private market insights and Moonfare updates – straight to your inbox.
At the same time, financing costs are falling and competition among lenders is picking up. Pent-up deal demand from CLO funds and private credit investors is being matched by banks’ appetite as they look to regain market share.
In 2024 to the end of Q3, debt to EBITDA multiples on US broadly syndicated loans (largely provided by banks) had risen to 5.1x versus 4.8x for full year 2023.¹⁷ This is putting some wind in the sails of exits via secondary buyouts — in Q3 2024, over half of US private equity exit value was sponsor-to-sponsor realisations, up from 47% in Q2.¹⁸ We expect this to continue through next year.
And finally, the decisive presidential win for Donald Trump could bring an exit activity bounce. Public markets reacted positively to the news as the fog of political uncertainty dissipated, lifting further the prospects for IPOs should stock markets continue rising.
Deregulation is also expected to be a major theme for a second Trump term. Increased anti-trust scrutiny and an active Securities and Exchange Commission under Joe Biden’s presidency will likely give way to a more relaxed approach, which could pave the way for increased M&A activity, including portfolio company sales.
Read our expanded report: The exit outlook for private equity is the brightest it’s been in years.
As financing conditions ease and the price expectations gap diminishes, green shoots are appearing in dealmaking. Global M&A activity rose by value and volume in Q3 2024 year on year, by 23% and 6%, respectively, according to S&P.¹⁹ Private equity activity is charting a similar course.
Our teams saw a notable increase in deal flow through the second half of 2024, particularly among mid-market managers, where a recovery has been gathering pace. In the first half of 2024, US mid-market buyouts rose by 12% by both value and count versus the same period in 2023. This is a higher increase than the broader US buyout market, which saw a 5% increase by value and a 9% increase by volume in the same period of 2024, according to Pitchbook.²⁰
As the chart above illustrates, overall private equity activity remains some way below the peak year of 2021 and the recovery remains incremental, but after two years of declining capital deployment, the market may have passed its nadir.
Private equity dealmakers are in more bullish mode than they have been for some time. In a recent KPMG survey, 84% said they expected 2025 to be busier than 2024 as concerns about company valuations and higher interest rates have receded since 2023.²¹
It’s a sentiment corporate finance advisers echo, too. In a recent paper on US mid-market private equity, DC Advisory says: “the capital deployment and exit starting gun has gone off”.²²
An established feature of private markets, co-investments have come into their own in recent years. As the amount of equity needed to complete deals has risen, GPs are increasingly offering co-investment opportunities to their LPs to plug the gap.
In a challenging fundraising environment, many GPs are also looking to co-investment partners to help their capital go further. Moonfare’s co-investment team, for example, reported a 46% CAGR in the number of co-investment deals reviewed between 2021 and 2024.²³
LP appetite for these deals also continues to grow. Around half of LPs surveyed for a recent Goldman Sachs Asset Management (GSAM) survey have allocations to co-investments, with 44% of them under-allocated, suggesting there is room for growth.²⁴ CalPERS is among those eyeing co-investment as a major part of its private markets exposure: of the $28 billion it deployed in private markets in the year to June 2024, $11 billion went to co-investments.²⁵
Create your free Moonfare account now to view our funds, get proprietary investment insights, performance data and more.
Create your free Moonfare account now to view our funds, get proprietary investment insights, performance data and more.
Create your free Moonfare account now to view our funds, get proprietary investment insights, performance data and more.
With deal financing conditions improving and equity proportions of deals starting to edge down,²⁶ co-investment capital may well flow to larger deals. This is especially likely given that many firms (beyond the mega-players) are not anticipating large size step-ups for their next fund.
The GSAM survey found that 30% of firms expect to raise the same or less in their next flagship fundraise than predecessor offerings; only 13% will look to raise a substantially larger fund.²⁷
Read our expanded report: PE investors want more co-investments. What’s fuelling their appetite?
Private equity valuations have been hotly debated over the past two years as the correction in LPs’ public markets value was not matched by a decline in their private markets portfolio values — with the exception of venture capital.²⁸
Yet much of the discussion fails to consider the lag in private markets valuation shifts — which is true when markets rise as well as fall. We’ve seen a notable rise in public company valuations over the past year, yet unrealised private markets portfolio valuations have not increased in line with this.
As the chart below from Neuberger Berman demonstrates, in the year to mid-November 2024, the S&P 500 index was up 22.1%, the NASDAQ by 21.8% and MSCI World by 19.3%, yet buyout fund valuations rose by only 5% and venture capital declined by 1.6%.²⁹
Yet if public markets continue their upward trajectory and inflation remains under control, it seems likely that private markets funds will mark up assets in their portfolios in 2025 to reflect more benign economic conditions and a smoother growth path for portfolio companies. Our team is already seeing this happen in high-growth areas such as AI-related businesses, cybersecurity and green energy.
We are also seeing higher entry multiples in the US, where EV/EBITDA multiples stretched to 15x for new deals in the first three quarters of 2024 (they had dipped to 12x in 2023), according to Pitchbook. One reason for this is that buyout firms have been concentrating on selling some of their best quality assets which typically command higher valuations.³⁰
However, the rise in entry multiples has not (so far) been evenly spread. The EV/EBITDA multiples for deals in North America and Europe combined have increased less sharply — from 11.2x in 2023 to 12.7x for the first three months of 2024,³¹ which suggests that European valuations remain low relative to those in the US.
There has been talk recently of a “golden age” for private credit as high interest rates bolstered private credit’s returns (given its largely floating rate structures) while bank retrenchment reduced competition and swung terms in lenders’ favour.
So could falling interest rates and a more competitive leveraged finance market remove some of private debt’s lustre? On paper, perhaps. Yet in reality, the asset class’s flexibility should continue to serve it well.
Interest rates will likely remain higher than many businesses had become accustomed to before the pandemic, and lower interest rate debt will mature over the coming years. Borrowers will therefore need to be creative about how they access finance and manage their balance sheets. This should open up opportunities for private credit funds, which are well suited to providing tailored funding that meets a company’s specific needs.
Investors seem to agree. At $207 billion, private debt fundraising was up in the first three quarters of 2024, compared to $193.6 billion in the same period last year, Private Debt Investor figures show, with over a third of funds exceeding their targets.³²
On track for a record-breaking 2024, secondary players have had a busy year. Deal volume surpassed $70 billion in the first half of 2024, according to Evercore data, setting the market on course for over $140 billion by year-end.³³
Secondary capital has been in high demand through the year as LPs and GPs have sought liquidity in an exit-constrained environment. For LPs, the motivation has been to unlock capital to fund existing commitments and make new fund investments.
GPs, meanwhile, have been under pressure to offer liquidity to their LPs and have tapped the secondaries market as a way of achieving this without having to sell prized assets in a flat M&A market. As a result, both LP-led and GP-led secondary deals have been more active than ever.
Secondaries fundraising has also been brisk in 2024, with totals set to match the all-time high of 2023, according to Secondaries Investor.³⁴ By the end of Q3 2024, secondaries funds had attracted $76.6 billion, just ahead of the $76.3 billion raised in the same period the year before.
With around $253 billion of capital at their disposal, secondaries funds will have sufficient dry powder to deploy in the opportunities that 2025 will present.³⁵
And there should be plenty of these. Should 2025 see a gradual recovery of exits and a rise in distributions, sellers using secondaries as a tactical tool will replace those motivated by today’s liquidity crunch.
A swathe of sellers new to the market — the proportion of LPs using the secondary market for the first time rose to 45% in H1 2024, up from 39% in 2023³⁶ — are now more comfortable with secondaries and may well return to fine-tune exposures and clean up portfolios.
The same is true on the GP-led side, where secondary deals are now an accepted exit route and a mainstream way of managing portfolios. GPs no longer need to sell their best assets to a competitor, for example, but can continue to create value. The growing number of dedicated GP-led funds raised by both primary GPs and established secondaries players supports this trend.
Growth will also come from the expansion of the primary market as record fundraising over the past decade translates into a growing pool of assets, some of which will turn over in the secondaries market.
After a choppy couple of years, venture capital is showing some signs of stabilising. The steep declines in valuations seen in 2022 are now starting to reverse, with global pre-money valuations all above 2019 thresholds in Q2 2024, Schroders analysis suggests.³⁷
Meanwhile, the first quarter of 2024 also saw venture capital performance move into positive territory after going negative in early 2022.³⁸
These positive signals put venture capital on a sounder footing for 2025, although gains have been hard-won. To get to this point, venture capital firms and founders have had to focus relentlessly on capital efficiency and profitability, with the “growth at all costs” mentality parked firmly in the past. A path to sustainable growth, favourable cash flow dynamics and a greater line of sight to profitability are the attributes venture capital firms seek out in today’s market.
This cautious and highly selective stance has subdued overall deal values and volumes they may not pick up meaningfully for a little while yet. In the US, deal values and volumes were broadly flat to Q3 2024 versus 2023,³⁹ while in Europe, they were on track to decline in 2024.⁴⁰ Exits have so far disappointed, although with rising valuations, we may see some movement later in 2025.
An exception is the rise of venture debt across both regions, where this lower cost form of financing (relative to equity) is attracting higher growth companies. It is also finding favour with venture-growth players seeking additional finance for portfolio companies without the risk of having to mark down their valuations in an equity fundraising round. In the US, 75% of venture debt went to venture growth companies in 2024,⁴¹ while in Europe, the proportion is even higher.⁴²
No-one is going to get fired for predicting that AI-related investment will be a mega-theme for 2025. For private equity firms seeking out stable businesses with predictable revenue streams and high cash generation, the prize lies in targeting areas where this game-changing technology can be applied to greatest effect.
As a result, industrials and business services are likely to be among the stand-out sectors for deal activity over the coming year.
While the first half of 2024 proved quiet on a global M&A front for the sector, PwC analysts were predicting a pick-up in the second half of the year and beyond as inflationary pressures receded and the transformational potential of new technologies became apparent.⁴³
Business services has long been a key private equity target and the need for investment in further digitalisation is adding to its attractiveness. Automation in legal, professional and marketing services are areas where private equity sees value creation potential. Consolidating what are often fragmented sub-sectors is also a big theme.
In industrials, the imperative to acquire capabilities in AI, predictive robotics and smart manufacturing is also fueling increased private equity interest. Investment in industrial automation companies, specifically, soared in the third quarter of 2024, to $11.4 billion versus just $780 million in the same period of 2023, according to S&P.⁴⁴ This was boosted by KKR’s take-private of Japanese industrial automation business Fuji Soft, the first stage of which completed in November.⁴⁵
Private equity’s agility can insulate the asset class from macroeconomic challenges, but it cannot bring immunity. With geopolitical tensions and conflict showing little sign of abating, private equity firms will need to continue navigating macro risks carefully. Indeed, 60% of GPs and LPs surveyed in a 2024 GSAM report said geopolitical risk was the biggest investment risk today — by far the top issue and higher than the 46% saying this in 2023.⁴⁶
With expectations that interest rates will not fall dramatically from where they are today, firms will also need to hone their value creation capabilities. GP responses in the GSAM survey demonstrate a clear focus on revenue growth to create value, both organically and via M&A.⁴⁷
While the prospect of recession in the US and in Europe appears to have faded for now,⁴⁸ ⁴⁹ there could be ripple effects from a second Trump presidency, potentially dragging on GDP growth next year and beyond if policies such as tariffs are enacted.
A narrowing IPO window is another risk that large GPs in particular will need to manage since there are limited alternative exit routes for their biggest deals. However, US IPO activity was up in Q3 2024, with proceeds in the first three quarters of the year higher than full-year 2023 totals, according to EY.⁵⁰ Absent any major shocks, lower interest rates could help sustain investor appetite for new issues for some time to come.
Read our expanded report: Five global themes that will shape 2025.
As we noted above, value creation will take centre stage for private equity investors. That’s true of new investments being made today and it’s also true of existing portfolio companies — given that 81% of PE executives in an EY survey said that holding periods have been extended by up to three years longer than the historical average.⁵¹
The same survey identified operational value-add as the driver of 52% of private equity deals expected to be exited in 2024-2025, versus just 31% of deals exited in 2021. Multiple expansion and leverage have receded significantly over the same period.⁵²
To combat higher interest rates and a lack of multiple expansion potential, GPs are doubling down on operational improvements, cost-cutting and technological enhancements to drive value.
Among the most effective actions in a higher interest rate environment are likely to be margin expansion in addition to revenue growth, by improving pricing strategy, sales force effectiveness, operational efficiency and product innovation. Bain & Company's analysis shows that around 15% of the returns generated from top-quartile deals stem from margin expansion.⁵³
This trend is seeing private equity houses bolster or re-organise their value creation capability, often by hiring operators with specific experience in areas such as supply chain management or technology integration and people with sector expertise, particularly in healthcare, technology and manufacturing.⁵⁴ ⁵⁵
Private markets appear to be moving on from the particularly challenging 2022-2023 period, with the coming year set for a continued recovery in activity levels. Over the next 12 months, investors should be prepared for:
These three points highlight the resilience of a diversified private markets exposure that includes secondaries and private debt as well as private equity, infrastructure and venture capital — the various characteristics of each segment can offer investors benefits at differing points of the cycle.
And while external shocks may affect private markets’ activity levels, the long-term nature of the asset class and its hands-on investment style protects and builds value in portfolios in good times and bad to generate the returns investors expect.
Important notice: This content is for informational purposes only. Moonfare does not provide investment advice. You should not construe any information or other material provided as legal, tax, investment, financial, or other advice. If you are unsure about anything, you should seek financial advice from an authorised advisor. Past performance is not a reliable guide to future returns. Don’t invest unless you’re prepared to lose all the money you invest. Private equity is a high-risk investment and you are unlikely to be protected if something goes wrong. Subject to eligibility. Please see https://www.moonfare.com/disclaimers.
¹ https://www.ey.com/en_gl/insights/private-equity/pulse
² https://files.pitchbook.com/website/files/pdf/Q3_2024_US_PE_Breakdown.pdf
³ https://files.pitchbook.com/website/files/pdf/Q3_2024_European_PE_Breakdown.pdf
⁴ https://pitchbook.com/news/reports/q3-2024-global-pe-first-look
⁵ https://www.spglobal.com/marketintelligence/en/news-insights/latest-news-headlines/rate-check-aging-portfolios-weigh-on-private-equity-managers-81958924
⁶ https://www.bain.com/insights/year-cash-became-king-again-global-private-equity-report-2024/
⁷ https://www.ey.com/en_gl/insights/private-equity/pulse
⁸ https://markets.businessinsider.com/index/msci-world
⁹ https://markets.businessinsider.com/index/s&p_500
¹⁰ https://eqtgroup.com/news/2024/galderma-the-pure-play-dermatology-category-leader-goes-public-on-the-six-swiss-exchange/
¹¹ https://www.partnersgroup.com/news-and-views/press-releases/investment-news/detail?news_id=0eb1282e-892c-4d7b-b244-f5196e414fd7
¹² https://ir.standardaero.com/news-events/press-releases/detail/97/standardaero-announces-launch-of-initial-public-offering
¹³ https://www.ft.com/content/412ea898-9422-4833-a56e-e69b6849b1ee
¹⁴ https://www.reuters.com/business/healthcare-pharmaceuticals/medline-industries-said-explore-ipo-2025-bloomberg-news-reports-2024-07-23/
¹⁵ https://assets.kpmg.com/content/dam/kpmg/uk/pdf/2024/08/ipo-market.pdf
¹⁶ https://am.gs.com/en-gb/institutions/insights/report-survey/private-markets-survey#
¹⁷ https://files.pitchbook.com/website/files/pdf/Q3_2024_US_PE_Breakdown.pdf
¹⁸ https://files.pitchbook.com/website/files/pdf/Q3_2024_US_PE_Breakdown.pdf
¹⁹ https://www.spglobal.com/market-intelligence/en/news-insights/research/global-m-a-by-the-numbers-q3-2024
²⁰ https://files.pitchbook.com/website/files/pdf/Q2_2024_US_PE_Middle_Market_Report.pdf
²¹ https://kpmg.com/us/en/media/news/kpmg-ma-deal-market-study-july-2024.html
²² https://www.dcadvisory.com/media/lkknq4n2/us-pe-mmm_oct_24_linked.pdf
²³ Moonfare Co-Investment Fund II Presentation, November 2024
²⁴ https://am.gs.com/en-gb/institutions/insights/report-survey/private-markets-survey
²⁵ https://www.calpers.ca.gov/docs/board-agendas/202409/invest/item06a-01_a.pdf
²⁶ https://files.pitchbook.com/website/files/pdf/Q3_2024_US_PE_Breakdown.pdf
²⁷ https://am.gs.com/en-gb/institutions/insights/report-survey/private-markets-survey
²⁸ https://www.ftadviser.com/investments/2024/08/30/early-stage-company-valuations-the-challenge-for-private-equity-investors/
²⁹ https://www.nb.com/handlers/documents.ashx?id=62ec8e46-0646-458c-8770-71c0f18c7290
³⁰ https://files.pitchbook.com/website/files/pdf/Q3_2024_US_PE_Breakdown.pdf
³¹ https://files.pitchbook.com/website/files/pdf/Q3_2024_US_PE_Breakdown.pdf
³² https://media.privatedebtinvestor.com/uploads/2024/10/q3-2024-fundraising-report-pdi.pdf
³³ https://www.evercore.com/wp-content/uploads/2024/07/Evercore-H1-2024-Secondary-Market-Survey-Results_vF.pdf
³⁴ https://www.secondariesinvestor.com/download-behind-q3s-massive-secondaries-fundraising-spike/
³⁵ https://go.jefferies.com/l/399542/2024-07-29/5rf791/399542/1722259035JFzPPUio/Jefferies___Global_Secondary_Market_Review___July_2024.pdf
³⁶ https://go.jefferies.com/l/399542/2024-07-29/5rf791/399542/1722259035JFzPPUio/Jefferies___Global_Secondary_Market_Review___July_2024.pdf
³⁷ https://mybrand.schroders.com/m/6052bc2f6f6b6f38/original/Q3-2024-Private-Equity-Lens.pdf
³⁸ https://mybrand.schroders.com/m/6052bc2f6f6b6f38/original/Q3-2024-Private-Equity-Lens.pdf
³⁹ https://files.pitchbook.com/website/files/pdf/Q3_2024_PitchBook-NVCA_Venture_Monitor.pdf
⁴⁰ https://files.pitchbook.com/website/files/pdf/Q3_2024_European_Venture_Report.pdf
⁴¹ https://files.pitchbook.com/website/files/pdf/Q3_2024_PitchBook-NVCA_Venture_Monitor.pdf
⁴² https://files.pitchbook.com/website/files/pdf/Q3_2024_European_Venture_Report.pdf
⁴³ https://www.pwc.com/gx/en/services/deals/trends/industrials-services.html#trends-accordion-industrial-manufacturing
⁴⁴ https://www.spglobal.com/marketintelligence/en/news-insights/latest-news-headlines/global-private-equity-investment-in-industrial-automation-surges-83445701
⁴⁵ https://media.kkr.com/news-details/?news_id=869bcd63-784f-4ee8-9f2e-8ad425f0d199&type=1
⁴⁶ https://am.gs.com/en-gb/institutions/insights/report-survey/private-markets-survey
⁴⁷ https://am.gs.com/en-gb/institutions/insights/report-survey/private-markets-survey
⁴⁸ https://www.cbsnews.com/news/us-gdp-2024-third-quarter-consumer-spending/
⁴⁹ https://www.goldmansachs.com/insights/articles/the-euro-area-is-forecast-to-avoid-recession-despite-trump-tariffs
⁵⁰ https://www.ey.com/en_us/insights/ipo/ipo-market-trends
⁵¹ https://www.ey.com/en_lu/insights/strategy-transactions/how-the-drivers-of-private-equity-value-creation-are-changing
⁵² https://www.ey.com/en_lu/insights/strategy-transactions/how-the-drivers-of-private-equity-value-creation-are-changing
⁵³ https://www.bain.com/globalassets/noindex/2024/bain_report_global-private-equity-report-2024.pdf
⁵⁴https://www.partnersgroup.com/en/news-and-views/firm-updates
⁵⁵ https://www.permira.com/news-and-insights/announcements/former-meta-executive-carolyn-everson-joins-permira-as-senior-adviser
Benefit from what institutional investors already know: the greatest shareholder value comes from private markets, and funds like those offered on Moonfare have generated an average IRR of 19% — outperforming the S&P 500 by 13%.*
Sign up now* Past performance is no guarantee of future returns.
Please read this important information. By selecting I AGREE this indicates that you have read and understand the below, before accessing the rest of this website.
This disclaimer is intended for UK readers accessing this website who should be aware that Moonfare cannot guarantee all information displayed on its website will be relevant or suitable for UK audiences. Moonfare cannot guarantee the information contained on its website is up to date, and makes best efforts to ensure it sources and data are accurate at the time of publishing.
The information on this website may not be suitable for all investors and we therefore need to ensure that you are sufficiently aware of the risks and are of a suitable category as defined by the Financial Services and Markets Act 2000.
The information set out in this website does not constitute or form part of any offer to issue or sell, or any solicitation of an offer to subscribe or purchase any investment, nor shall it or the fact of its distribution form the basis of, or be relied on in connection with any contract.